idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
Scientists at the University of Duisburg-Essen are researching new therapies for aggressive forms of childhood leukaemia. For the first time, their approach tries to distinguish between two subtypes using so-called nanobody PROTACs. These attack diseased tissue while sparing healthy cells. The José Carreras Leukaemia Foundation is supporting the project, led by Prof. Dr. Shirley Knauer and Dr. Mike Blueggel from the Faculty of Biology, with 143,740 euros for two years.
The research focuses on molecules that break down certain proteins in cancer cells: nanobody PROTACs (proteolysis targeting chimeras). They couple a binding molecule for the target protein with a signal that causes the cell to destroy this particular protein. This allows a disease-relevant protein to be removed in a targeted manner without damaging healthy structures.
The target protein in this case is the enzyme Taspase 1, which plays a central role in particularly aggressive forms of acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML). So far, it has been difficult to develop effective strategies against this enzyme. Therefore, researchers are now exploiting differences in the internal degradation machinery of cancer cells for the first time: they want to develop PROTACs that specifically degrade Taspase 1 in the respective form of leukaemia.
Another innovation is the use of so-called helicons – small spiral-shaped proteins that, as part of biological PROTACs, establish a connection with the degradation factors described above. This enables the targeted destruction of the protein of interest.
‘With this dual novel approach, we are opening up an entirely new avenue for personalised leukaemia treatment,’ explains Dr. Mike Blueggel. ‘This project could be groundbreaking, not only for research, but also for the long-term treatment of these particularly aggressive diseases.’
Editor: Birte Vierjahn, +49 203/37 9-2427, birte.vierjahn@uni-due.de
Dr. Mike Blueggel, Molecular Biology II, +49 203/37 9-2526, mike.blueggel@uni-due.de
Prof. Dr. Shirley Knauer, Molecular Biology II, +49 203/37 9-3355, shirley.knauer@uni-due.de
https://www.uni-due.de/zmb/molecular-biology-knauer/research.php
Artistic representation of some of the structures described: A white leukaemia cell floats in the bl ...
Copyright: UDE / Shirley Knauer, generated with AI
Merkmale dieser Pressemitteilung:
Journalisten
Biologie, Medizin
überregional
Forschungsprojekte
Englisch
Artistic representation of some of the structures described: A white leukaemia cell floats in the bl ...
Copyright: UDE / Shirley Knauer, generated with AI
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
